Fibrin Patch: Completed Phase II enrollment

Omrix completed enrollment of the first cohort of 90 patients in a Phase II trial to evaluate the Fibrin Patch vs. Surgicel. If the interim efficacy analysis from the first cohort demonstrates superio...